juglone has been researched along with Colonic Neoplasms in 6 studies
juglone: structure
juglone : A hydroxy-1,4-naphthoquinone that is 1,4-naphthoquinone in which the hydrogen at position 5 has been replaced by a hydroxy group. A plant-derived 1,4-naphthoquinone with confirmed antibacterial and antitumor activities.
Colonic Neoplasms: Tumors or cancer of the COLON.
| Excerpt | Relevance | Reference |
|---|---|---|
| " This study implies the therapeutic effect of IND and juglone [JUG] against colon carcinogenesis, without gastric ulceration - an adverse side effect of IND." | 8.02 | Effects of combined treatment with Indomethacin and Juglone on AOM/DSS induced colon carcinogenesis in Balb/c mice: Roles of inflammation and apoptosis. ( Devaraj, H; Seetha, A; Sudhandiran, G, 2021) |
| " This study implies the therapeutic effect of IND and juglone [JUG] against colon carcinogenesis, without gastric ulceration - an adverse side effect of IND." | 4.02 | Effects of combined treatment with Indomethacin and Juglone on AOM/DSS induced colon carcinogenesis in Balb/c mice: Roles of inflammation and apoptosis. ( Devaraj, H; Seetha, A; Sudhandiran, G, 2021) |
| "Treatment with juglone was not as effective as with indomethacin; however, a combination of both was shown to be more effective, suggesting that juglone may be considered for therapeutic intervention of colon cancer." | 1.56 | Indomethacin and juglone inhibit inflammatory molecules to induce apoptosis in colon cancer cells. ( Devaraj, H; Seetha, A; Sudhandiran, G, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 3 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Seetha, A | 2 |
| Devaraj, H | 2 |
| Sudhandiran, G | 2 |
| González-Montiel, GA | 1 |
| Kaweesa, EN | 1 |
| Feau, N | 1 |
| Hamelin, RC | 1 |
| Stone, JK | 1 |
| Loesgen, S | 1 |
| Spoerlein-Guettler, C | 1 |
| Mahal, K | 1 |
| Schobert, R | 1 |
| Biersack, B | 1 |
| Sugie, S | 1 |
| Okamoto, K | 1 |
| Rahman, KM | 1 |
| Tanaka, T | 1 |
| Kawai, K | 1 |
| Yamahara, J | 1 |
| Mori, H | 1 |
| Kamei, H | 1 |
| Koide, T | 1 |
| Kojima, T | 1 |
| Hashimoto, Y | 1 |
| Hasegawa, M | 1 |
6 other studies available for juglone and Colonic Neoplasms
| Article | Year |
|---|---|
Indomethacin and juglone inhibit inflammatory molecules to induce apoptosis in colon cancer cells.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Prot | 2020 |
Chemical, Bioactivity, and Biosynthetic Screening of Epiphytic Fungus
Topics: Anti-Bacterial Agents; Ascomycota; Biosynthetic Pathways; Cell Proliferation; Colonic Neoplasms; Gen | 2020 |
Effects of combined treatment with Indomethacin and Juglone on AOM/DSS induced colon carcinogenesis in Balb/c mice: Roles of inflammation and apoptosis.
Topics: Animals; Apoptosis; Azoxymethane; Carcinogenesis; Cell Count; Cell Line, Tumor; Collagen; Colonic Ne | 2021 |
Ferrocene and (arene)ruthenium(II) complexes of the natural anticancer naphthoquinone plumbagin with enhanced efficacy against resistant cancer cells and a genuine mode of action.
Topics: Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B; Cell Cycle; Cell L | 2014 |
Inhibitory effects of plumbagin and juglone on azoxymethane-induced intestinal carcinogenesis in rats.
Topics: Animals; Antineoplastic Agents, Phytogenic; Azo Compounds; Benzopyrans; Colonic Neoplasms; Coumarins | 1998 |
Inhibition of cell growth in culture by quinones.
Topics: Anthraquinones; Antineoplastic Agents; Arbutin; Cell Division; Colonic Neoplasms; Humans; Naphthoqui | 1998 |